CAPTAIN PAUL WATSON TO LEAD EFFORT TO HALT JAPANESE WHALING IN SOUTHERN OCEAN SANCTUARY
MEDIA PARIS, April 4, 2024 /PRNewswire/ — In a bold move to protect the sanctity of the Southern Ocean Whale Sanctuary, renowned environmentalist Captain Paul Watson, alongside the dedicated crew of Neptune’s Pirates, is set to embark on a crucial mission to thwart Japan’s resumpti
Silver Star Properties REIT, Inc. To Reduce Operating Expenses
HOUSTON, April 3, 2024 /PRNewswire/ — Silver Star Properties REIT, Inc. (“Silver Star” or the “Company”) is a self-managed real estate investment trust that is currently repositioning in an orderly manner into the self-storage asset class. Hartman SPE, LLC (the “
Affinity Biosensors Receives FDA Clearance for the LifeScale AST System
SANTA BARBARA, Calif., April 3, 2024 /PRNewswire/ — Affinity Biosensors, a leading innovator in the field of healthcare diagnostics, announces that its groundbreaking LifeScale AST system has received FDA clearance. This milestone gives healthcare professionals an important tool for managing
Vyopta is a Three-Time Recipient of the Frost & Sullivan Best Practices Award
AUSTIN, Texas, April 3, 2024 /PRNewswire/ — Vyopta, the global leader in digital collaboration and experience optimization, announces today that Frost & Sullivan has recognized Vyopta with a Best Practices Award for Customer Value Leadership for its differentiated value and strong overall
Partner Therapeutics’ Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin® PMDA Approval of Sargmalin is the first regulatory approval of an inhaled recombinant GM-CSF product for aPAP LEXINGTON, Mass., April 3, 2024 /PRNewswire/ — Partner Therapeutics, Inc. (PTx) announced that its p
Partner Therapeutics’ Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin® PMDA Approval of Sargmalin is the first regulatory approval of an inhaled recombinant GM-CSF product for aPAP LEXINGTON, Mass., April 3, 2024 /PRNewswire/ — Partner Therapeutics, Inc. (PTx) announced that its p
Vyopta is a Three-Time Recipient of the Frost & Sullivan Best Practices Award
AUSTIN, Texas, April 3, 2024 /PRNewswire/ — Vyopta, the global leader in digital collaboration and experience optimization, announces today that Frost & Sullivan has recognized Vyopta with a Best Practices Award for Customer Value Leadership for its differentiated value and strong overall
Affinity Biosensors Receives FDA Clearance for the LifeScale AST System
SANTA BARBARA, Calif., April 3, 2024 /PRNewswire/ — Affinity Biosensors, a leading innovator in the field of healthcare diagnostics, announces that its groundbreaking LifeScale AST system has received FDA clearance. This milestone gives healthcare professionals an important tool for managing
Silver Star Properties REIT, Inc. To Reduce Operating Expenses
HOUSTON, April 3, 2024 /PRNewswire/ — Silver Star Properties REIT, Inc. (“Silver Star” or the “Company”) is a self-managed real estate investment trust that is currently repositioning in an orderly manner into the self-storage asset class. Hartman SPE, LLC (the “
CAPTAIN PAUL WATSON TO LEAD EFFORT TO HALT JAPANESE WHALING IN SOUTHERN OCEAN SANCTUARY
MEDIA PARIS, April 4, 2024 /PRNewswire/ — In a bold move to protect the sanctity of the Southern Ocean Whale Sanctuary, renowned environmentalist Captain Paul Watson, alongside the dedicated crew of Neptune’s Pirates, is set to embark on a crucial mission to thwart Japan’s resumpti
